Updates in measles control in the African Region Measles Partnership Annual Meeting September 2008 Dr Balcha G Masresha WHO AFRO.

Slides:



Advertisements
Similar presentations
Progress in Measles Control in the African Region Annual Measles Partnership meeting Feb 2007 Washington DC.
Advertisements

OVERVIEW OF POLIO ERADICATION INITIATIVE IN THE AFRICAN REGION COMMUNICATION MEETING MEETING DAKAR – SENEGAL 5 TH TO 7 TH APRIL 2008.
Follow-up consultation on the TFI recommendation for communication for EPI/Polio Objectives, expected outcomes and methodology Paryss Kouta, UNICEF WCARO.
TFI recommendation for communication Polio/EPI Results from the follow-up consultation on Polio/EPI indicators Paryss Kouta, UNICEF WCARO Dakar - Senegal,
Integrated Maternal And Child Health Campaign in Ghana By Georgina Amidu Programme Communication Officer UNICEF/Ghana 8 th April 2008, Dakar - Senegal.
Synergies between the GAVI Alliance and health systems strengthening Dr. Craig Burgess, GAVI Secretariat 29 May 2008.
Avian Influenza Prevention and Control Strategies, Including the Use of Vaccination Dr Bernard Vallat Director General OIE 4 th International Conference.
Monitoring the impact of vaccination on rubella and CRS Susan E. Reef, MD 11 th Annual Meeting The Measles and Rubella Initiative Sept. 19, 2012.
Impact of Large-Scale Infant Feeding Promotion on Child Survival and Health in Madagascar.
Global Measles and Rubella Strategic Plan
Karin Weyer WHO Stop TB Department Stop TB Partnership Global Laboratory Initiative.
Pre Tender Meeting UNICEF Supply Division Copenhagen 10-11th December 2008 Siri Bjornstad Yellow Fever Vaccine Tender
From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
WHO Regional Director for the Western Pacific Dr Shin Young-soo Malaria in the Pacific – Successes and Challenges.
House-to-House Social mobilization for Measles/Rubella SIAs in Rwanda, March 2013 American Red Cross to RWANDA RED CROSS.
Measles elimination in the African Region- Regional updates
1 June 2011 Measles update- India Dr. Satish Kumar Gupta Health Specialist UNICEF- India 13 th September 2011.
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
Measles Outbreaks in Southern Africa in 2010 Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Ann Levin, Colleen Burgess, Lou Garrison, Chris Bauch, and Joseph Babigumira Measles Initiative Meeting Washington, D.C. September 13,
1 AFRO Measles TAG – Nairobi 2-3 June 2015 MCV2 Introduction and the Second Year of Life Contact Lessons and way forward Raoul KAMADJEU UNICEF ESARO Meeting.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Measles Initiative Financing February 28, 2007 Washington, D.C. Andrea Gay UN Foundation for Measles Partners.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
What is “Reaching Every District” (RED) in Immunization? A brief overview Information from the global immunization partnership presented by Lora Shimp.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
IMMUNIZATION IN UGANDA Dan Wamanya IMMUNIZATION IN UGANDA Dan Wamanya USAID/Uganda.
Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,
Palestine Bahrain Global Measles and Rubella Management Meeting Boubker Naouri March, 2011 Geneva, WHO HQ.
Measles in EMR 7 th Annual Meeting of Partners for Measles Advocacy Washington, 2007.
MEASLES MORTALITY REDUCTION IN INDIA Status and Future Plans.
Current Status of Immunization Service Delivery in Africa Mary Harvey AFR/SD/HRD SOTA/PHN Meeting June 13, 2002.
Measles Initiative Management and Financing September 13, 2011.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Funding Update: 2013 – 2015 September 10,
Measles pre-elimination in the African Region. Presentation to the MI 10 th annual meeting Sept 2011 B Masresha WHO AFRO.
Global Overview of Measles & Rubella 11 th Annual Meeting The Measles Initiative Washington, DC th September, 2012.
APPLYING LESSONS LEARNED TO FOLLOW-UP CAMPAIGNS, NIGERIA
Regional measles elimination program updates B Masresha WHO AFRO AFR MR TAG Meeting Nairobi, June 2015.
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
Status of EPI In Guinea DR. Mariama BAH Child Survival Advisor USAID/Guinea June 13, 2002.
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
12 th Annual Meeting The Measles & Rubella Initiative Western Pacific Regional Update: The Final Push September 2013 American Red Cross National.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September
Accelerating progress towards MR elimination, |1 | Update from Regional Measles & Rubella Laboratory Network, African Region Hotel Royal, Geneva,
Accelerating Progress towards Measles and Rubella Elimination Eastern Mediterranean Region 1 21 June 2016 Geneva, Switzerland.
Global Measles and Rubella: Highlights, Priorities and Critical Issues
Balcha Masresha WHO AFRO June 2016
Accelerating Progress towards Measles and Rubella Elimination in AFR
Global Overview of Measles
23 November, 2018 Update on measles & rubella surveillance in the WHO African Region – progress and challenges Dr Richard Luce WHO/IST-Central 5th African.
African Region- priorities to reach the 2020 measles elimination goal.
Funding Update: Current Situation and Future Prospects
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Maintaining Elimination in an Environment of Persistent Importation
Partners for Measles Advocacy—7th Annual Meeting
YELLOW FEVER VACCINE AVAILABILITY AND NEEDS FOR THE AFRICAN REGION
Presentation transcript:

Updates in measles control in the African Region Measles Partnership Annual Meeting September 2008 Dr Balcha G Masresha WHO AFRO

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Outline of presentation Regional measles control goal and current status Routine immunisation Supplemental immunisation activities Measles case-based surveillance Programmatic challenges The pre-elimination goal for the African Region

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Estimated reduction in measles mortality (all ages) in the African Region, % reduction

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Reported coverage vs WHO UNICEF estimates. AFR

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Measles vaccination administrative coverage by category. AFR

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa DPT1 – measles drop out rates. (WHO UNICEF estimates. 2006) 33 of 46 countries with drop-out rates >10% 11 countries with drop out rates 20% 3 countries with DTP1 90% with drop out rates 20%

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Stagnating coverage / high drop out rates… WHY? Infrastructure, financial and human resource limitations Limited geographic access and utilisation access for routine services Gaps in implementing the RED strategy: Outreach, community linkages, use of data for action, appropriate management of resources Logistics gaps including vaccine stock outs, aging cold chain and EPI vehicle fleet Inaccuracy of denominators… Improved quality of coverage reporting (e.g., administrative coverage data from CHWs / IPDs)

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa MP support for focused routine immunisation strengthening In 2008, 9 countries were supported financially A total of USD 1,050,000 Support focused to avert measles outbreaks, de-linked from the SIAs (i.e., these 9 countries were not scheduled for SIAs in 2008)

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa TAG Criteria for considering MCV2 MCV1 coverage >80%, for > 3 consecutive years (using WHO/UNICEF coverage estimates) and Attainment of one of the two primary measles surveillance performance indicators for at least two consecutive years. i.e., Non-measles febrile rash illness rate of > 2.0 cases per 100,000 population per year At least 1 suspected measles case investigated with blood specimens in > 80% of districts per year.

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Second Opportunity for measles vaccination (SIAs)

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Children reached in measles SIAs, 2001 – 2007, and target plans for AFR

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Measles SIAs; results 97 SIAs in 43 countries reaching million children from 2001 – end of rounds with admin coverage 90 – 94% 20 rounds with admin coverage < 90% By end of 2008, a further 63.4 million children will be targeted in 9 countries

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Measles SIAs: some examples of coverage gaps Gabon, Nov % MCV 98% ITN Ghana, % MCV Guinea Bissau, 2006; 85% MCV Nigeria, 2006; 83% MCV

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Measles Follow up SIAs Coverage by Region, Ethiopia. April - May 2008

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Intervention Measles15 countries14 countries10 countries Vit A12138 Deworming7116 ITNs776 OPV525 Integrated delivery of interventions in measles SIAs

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Integration in measles SIAs; AFR. 2007

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Integrated delivery of multiple interventions; is it always synergistic? Integration may be seen as being partner-led room for advocacy and local consensus building Weakness of central coordination Need for stronger involvement of all programs Delays in program level decisions/ resources/ logistics Stock-out of commodities disrupting acceptance of antigens; appropriate and detailed logistic planning Need for further operational research on the factors conducive to the synergy

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Measles case based surveillance

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa The Regional measles surveillance network 40 countries (749.4 million population) under case based surveillance with a network of National / Regional Referral measles laboratories Heavily dependent on the Polio infrastructure Staffing, vehicles, funding for activities …

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Measles surveillance performance & results. AFR – July 2008 Indicator/ parameter # suspected cases reported % investigated with blood specimens (target: >80%) 93%92%96% % districts reporting at least 1 suspected case (target: >80%) 54%71%68% % lab confirmed cases (target:<10%)30%22%25% # total confirmed measles cases Incidence of confirmed measles per 100,000 population Annualised non measles febrile rash illness rate (target >2:100,000)

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Measles incidence Regional incidence: > 10 cases per million for the last 3 years; Country incidence levels ranging from 0 – 60 cases per million

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Incidence per 100,000 population # of countries% of total regional population < % 0.1 – % 0.5 – % 1.0 – % >/= % Measles incidence. AFR. 2007

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Incidence of confirmed measles. Jan – June AFR

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Trends of measles case reports. Nigeria Measles catch up campaign in Northern states Measles catch up campaign in Southern states 2008

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Measles case reports by final classification, Nigeria vs 2008 Jan – Dec 2007 Jan – Mar 2008 Jan – Mar 2007

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Age & vaccination status of confirmed measles cases, Nigeria. Jan – Dec 2007 (n=2,297)

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa LGAs with reported measles outbreaks. Jan – July 2008, Nigeria

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Age & vaccination status of confirmed measles cases. Nigeria, Jan – Jul 2008 (n=8,887)

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Challenges for measles control in AFR Limitations in SIAs operational funding Currency exchange rates, Rising costs of fuel, Rising staff costs, … Limited local mobilization of $ resources for operational component of SIAs Complacency following significant reduction of measles case burden Gaps in SIAs coverage, surveillance performance… System-wide constraints preventing sustained increase of routine immunization coverage beyond 80% New Regional measles targets: pre-elimination

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Plans for Measles SIAs in countries = 39.7 million children Total cost of $49.7 million including surveillance support to 40 countries Focused support to close routine immunization program gaps and avert outbreaks in countries scheduled for SIAs in 2010 Expected MP portion of $37.8 million Local sources expected to raise $11.9 million MP role in advocacy!!!

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Pre-elimination regional goal to be achieved by end-2012Pre-elimination regional goal to be achieved by end-2012 Targets: >98% mortality reduction by 2012 as compared to estimates for 2000; Measles incidence <5 cases/10 6 population/year at national level in all countries; >90% routine MCV1 coverage at national level, and >80% in all districts; >95% SIAs coverage in all districts; AND…

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa … continued Measles surveillance performance: Non-measles febrile rash illness rate of >2.0 cases per 100,000 population per year; 1 suspected measles case investigated with blood specimens in at least 80% of districts per year; and Routine district reporting from 100% of districts. Pre-elimination regional goal to be achieved by end-2012 (contd)

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa Working towards the pre-elimination targets: anticipated challenges Overcoming the complacency and maintaining the political will to scale up measles control activities to pre-elimination levels esp. while polio eradication still poses a challenge Raising the required $ resources (at international and local levels) Maintaining the surveillance infrastructure Attaining the ambitious routine immunization goals of >90% MCV at national level and >80% in all districts

Bureau Régional de lOMS pour lAfrique /WHO Regional\Office for Africa The Measles Partnership